Stable cleatine amidinohydrolase pharmaceutical
Abstract
Abstract PURPOSE:A stable cleatine amidinohydrolase pharmaceutical containing a nonionic surfactant, etc. having >=14 hydrophilic-lipophilic balance (HLB) as a stabilizer without causing the deterioration nor clouding even in preservation in the form of a solution. CONSTITUTION:A cleatine amidinohydrolase pharmaceutical containing within 0.01-1,000mg range based on 100 units cleatine amidinohydrolase one or more stabilizers selected from the group consisting of a nonionic surfactant, e.g. polyoxyethylene alkyl phenyl ether or polyoxyethylene acyl ester, having >=14 hydrophilic-lipophilic balance (HLB) a chelating agent, e.g. ethylenediaminetetraacetic acid, and a preservative, e.g. azide, antibiotic substance and sulfamide agent therein.
Inventors
- 👤 Sachiko Yamaguchi
- 👤 山口 佐知子
- 👤 Yasuo Iwaki
- 👤 岩城 康雄
- 👤 Yuzo Hayashi
- 👤 林 勇藏
- 👤 Noboru Mitsuhida
- 👤 光飛田 登
- 👤 Minoru Ando
- 👤 實 安藤
Bibliographic Details
Claims Analysis
Total Claims: 0References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.